Authored By: Sarah
11 Jul 2024

 Arbovirus Testing Market Size to grow by USD 250.1 million between 2024-2028

According to a research report “ Arbovirus Testing Market” by End-user (Diagnostic laboratories, Hospitals, Research centers, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 250.1 million, at a CAGR of  4.5% during the forecast period. The global arbovirus testing market is experiencing significant growth due to the rising prevalence and diagnosis of arbovirus infections, particularly in hyperendemic regions such as Bangladesh and India. Arboviruses, including dengue and chikungunya, have posed a substantial health burden to affected populations. Although there have been approvals of drugs for arbovirus treatment, the necessity for accurate and efficacious testing remains crucial. The discovery of new treatment regimens and advancements in diagnostic techniques will positively impact market expansion. For instance, in recent years, Bangladesh has witnessed an increase in vector-borne disease outbreaks, particularly in Dhaka city, emphasizing the importance of reliable arbovirus testing solutions.

Browse market data tables, figures, and in-depth TOC on “Arbovirus Testing Market” by End-user (Diagnostic laboratories, Hospitals, Research centers, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By End-user, the Diagnostic laboratories segment is projected to dominate the market size in 2024


By Geography, North America  segment is expected to hold the largest market size for the year 2024

The arbovirus testing market represents a significant business opportunity due to the increasing prevalence of arboviral diseases worldwide. This market is driven by the rising demand for accurate and timely diagnosis of arboviral infections, as well as the development of advanced diagnostic technologies. Key players in this market focus on innovation and collaboration to offer comprehensive testing solutions that cater to both clinical and research applications. The market's growth is further fueled by government initiatives and private investments aimed at improving disease surveillance and control.

North America is forecasted to hold the largest market size by region in 2024

The arbovirus testing market witnesses significant growth due to the increasing prevalence of arboviral diseases and the need for early and accurate diagnosis. Laboratories and diagnostic centers invest in advanced technologies, such as real-time PCR and ELISA, to enhance their testing capabilities and meet the rising demand. Government initiatives and collaborations with key players further fuel market expansion.

The Arbovirus Testing Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • AESKU.GROUP GmbH and Co. KG
  • Agilent Technologies Inc.
  • ARUP Laboratories
  • Bio Rad Laboratories Inc.
  • BioAgilytix Labs
  • Copley Scientific Ltd.
  • DiaSorin SpA
  • Distek Inc.
  • Fluke Biomedical
  • Laboratory Corp. of America Holdings
  • Mayo Foundation for Medical Education and Research
  • Merck KGaA
  • NovaTec Immundiagnostica GmbH
  • Perkin Elmer Inc.
  • Response Biomedical Corp.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Arbovirus Testing Market plays a crucial role in disease prevention strategies, outbreak response, and patient management for various arboviral diseases such as West Nile fever, Zika virus infection, dengue fever, Chikungunya, and encephalitis. Arboviruses are transmitted by arthropods, primarily mosquitoes and ticks, making surveillance and diagnostic testing essential for public health interventions. Public health laboratories, diagnostic centers, and hospitals employ various diagnostic tests for arbovirus detection, including ELISA tests, RT PCR tests, next-generation sequencing, and lateral flow assays. These tests aid in the early identification and diagnosis of arboviral diseases, enabling effective patient management and reducing the spread of infection. Outbreak response strategies include the use of IVD (in vitro diagnostic) tests for rapid diagnosis and the implementation of public health interventions such as mosquito control measures and vaccination programs. Neglected tropical diseases like Powassan and other arboviral infections also require diagnostic testing and intervention to prevent further transmission and complications. Overall, the Arbovirus Testing Market plays a vital role in ensuring effective disease prevention, outbreak response, and patient management for various arboviral diseases, making it an essential component of global public health efforts.

Market Research Overview

The Arbovirus Testing Market encompasses diagnostic tests for Viruses transmitted by arthropods, including mosquitoes and ticks. With the increasing global prevalence of viral diseases such as Dengue Shock Syndrome and Dengue Haemorrhagic Fever, West Nile Fever, Zika Virus Infection, Chikungunya, Powassan, and Yellow Fever, comprehensive Surveillance Programs and integrated response strategies have become crucial. Laboratory networks and healthcare institutions employ various diagnostic tests like ELISA based Tests, IVD, RT PCR tests, Next generation sequencing, and Lateral flow assays for detection and response. Public health laboratories and diagnostic centers play a vital role in surveillance and testing, implementing disease prevention strategies, and outbreak response. Climate change poses a significant risk to the spread of Arthropod Borne Viruses, necessitating continuous risk monitoring and control measures. Healthcare spending on Arbovirus Testing Market is expected to increase due to the growing geriatric population, who are more susceptible to these diseases. Research Centers and diagnostic laboratories are developing advanced diagnostic tools to improve patient management and pandemic prevention. Neglected Tropical Diseases, such as Yellow Fever and Zika, also require increased attention and resources for effective surveillance and testing.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!